Few historical Chinese acquisitions:
1. TianQi Lithium: Acquisition price was about A$163/t.
in 2012, acquired Talison (100%) for total about CNY5b (~A$1b) in 2012 before lithium boom, then sold 49% to Rockwood for US$475m; (Greenbushes deposit:118.5Mt @2.4% Li2O - 6.1Mt LCE)
AVZ's Manono deposit exploration target: 1Bt - 1.2Bt @1.25% - 1.5% Li2O (AVZ's shared mid figure: ~19.65Mt LCE, Three times of Greenbushes'.
Lithium price is up +300% since 2012.
Based on TianQi Lithium acquisition of Talison/Greenbushes depoisit in WA, for $1b in 2012,
AVZ's attributable Exploration targeted lithium resource is three times of Greenbushes',
Theoretically, $1b (TianQi Lithium paid) x 3 times deposit x 4 (300% increase in lithium price 2012-2017) = $12b,
then Discounted for RISK factor ratio (Early exploration stage, country risk)
2. LATEST ACQUISITION IN CHINA: Acquisition price was about A$297/t.
On 16 October 2017, a Chinese company bought 60% of a Canadan lithium deposit (still in development, not in production yet) with lithium resource of 14.25Mt @1.4% Li2O (M&I:12Mt), total LCE 0.258Mt for US$60m.
Yesterday, news reported, some shareholders of the vendor complained the project was sold too cheap.
3. AVZ current valuation : A$26/t on a fully diluted basis
AVZ's middle figure of attributable (Exploration target) LCE is about 19.7Mt.
AVZ, currently is standing at $26/t, compared with ASX peer's average $274/t;
recent China's acquisition of a small lithium deposit: $297/t.
DYOR & GLTAH.
- Forums
- ASX - By Stock
- AVZ
- Running Commentary on the SP Movements.
Running Commentary on the SP Movements., page-3142
-
- There are more pages in this discussion • 15,412 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVZ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online